Latest stories on DSGN
Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference | DSGN Stock News
StockTitan50 · neutralgeneral
Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia - Slideshow
Seeking Alpha50 · neutralproduct/pr
Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript
Seeking Alpha50 · neutralproduct/pr
Jim Cramer on Design Therapeutics: “Pure Spec, Pure Spec”
Yahoo Finance31 · bearishanalyst